SCHEMBL26550293

SCHEMBL26550293

CC(C)Nc1cc(OCCN(C)C)ncn1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.41
HTR6 P50406 1/20 0.36
MAPT P10636 1/20 0.36
DNM2 P50570 2/20 0.35
BRAF P15056 1/20 0.35
KDR P35968 1/20 0.35
MAPK14 Q16539 1/20 0.35
TNNI3K Q59H18 1/20 0.35
ATM Q13315 1/20 0.35
P4HTM Q9NXG6 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
CCNT1 O60563 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
CDK9 P50750 1/20 0.34
HSF1 Q00613 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26547875 0.88 HTR7 (0.39) HTR7HTR6MAPTDNM2P4HTM
SCHEMBL26547873 0.81 MAPK14 (0.38) HTR7BRAFKDRMAPK14TNNI3K
SCHEMBL7998281 0.79 HTR6 (0.42) HTR7HTR6MAPTATM
SCHEMBL7999124 0.76 HTR7 (0.41) HTR7HTR6ATMCHRNB2CHRNA4
SCHEMBL12411077 0.75 NPC1 (0.44) MAPTBRAFKDRMAPK14TNNI3K
SCHEMBL26550287 0.75 CHRNB2 (0.44) HTR7MAPTCHRNB2CHRNA4
SCHEMBL12820402 0.75 HTR7 (0.40) HTR7HTR6MAPTATMCHRNB2
SCHEMBL15114898 0.74 HTR7 (0.47) HTR7HTR6MAPTP4HTMCHRNB2
SCHEMBL5416069 0.73 BRAF (0.35) BRAFKDRMAPK14TNNI3K
SCHEMBL2237291 0.72 HTR7 (0.46) HTR7HTR6MAPTP4HTMCHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed